Redefining Medicine

Dr. Vincent Pedre, a renowned expert in gut health, discusses his book The GutSMART Protocol in the upcoming episode of Redefining Medicine. In this episode, he emphasizes the importance of personalized approaches to gut health, highlighting that there is no "one-size-fits-all" solution. He delves into the connection between gut health and overall well-being, including its impact on skin health. The book also includes a quiz designed to help readers identify their specific gut-related issues, including those that may manifest as skin-related conditions. This quiz serves as a tool to guide individuals toward tailored protocols for improving their gut and skin health. Dr. Pedre's approach integrates diet, lifestyle changes, and targeted interventions to address unique gut health challenges.

In this episode of the Innovations and Clinical Implementation podcast, hosts Jessica Carter and Dr. Chris D'Adamo interview Dr. Jill Carnahan, a functional medicine physician internationally recognized for treating complex chronic illnesses, about the critical role of beta glucans in immune resilience – which she champions as the foundation of longevity. Dr. Carnahan, discusses the importance of using high-purity beta glucans, profiling BWH Labs' flagship product, and details their use in treating complex conditions like Lyme disease, Bartonella, and cancer where the immune system is often suppressed. The conversation also covers emerging research linking beta-glucan supplementation to improved mental health scores (anxiety and depression) and its mechanism as a binder in detoxification pathways for removing environmental toxins. Finally, Dr. Carnahan underscores that while lifestyle factors like sleep and movement are foundational, beta-glucans serve as a crucial tool for "waking up" sluggish T-cells and Natural Killer cells to fight aging and chronic illness. For access to episode resources, click HERE.

In this episode of the Innovations and Clinical Implementation podcast recorded at LongevityFest 2025, hosts Dr. Lexi Gonzales and Tom Blue explore the frontier of liposomal peptide therapy with Dr. Christopher Shade—the founder and CEO of Quicksilver Scientific and an internationally recognized expert on environmental toxicants who pioneered the use of lipid-based nanoparticle delivery systems. Dr. Shade argues that "inflammaging" and endotoxemia often block the efficacy of standard hormone therapies by downregulating receptors, and he advocates for using specific liposomal peptides like BPC-157, KPV, and Thymulin to break these inflammatory cycles and reverse "fatty thymus." The conversation details how intraoral nanoliposomes utilize membrane fusion to achieve high intracellular uptake, offering practitioners a compliant, scalable method to transition from symptom-chasing "personalized medicine" to upstream "precision medicine" that rapidly seals the gut and resets immune resilience. For access to episode resources, click HERE.

Greg Kelly, naturopathic physician and longevity product leader, outlines a practical, cyclical approach to cellular rejuvenation. He compares senescent cells to yellow leaves that need periodic pruning. He explains why clearing inflammatory cells first improves stem cell support and describes a simple monthly rhythm of short senolytic pulses followed by stem cell support.

On the next episode of Redefining Health, we'll be joined by Christopher Davis to dive into the fascinating topic of metabolic health—what it truly means and how practitioners can effectively discuss it with their patients. Metabolic health is deeply tied to mitochondrial function, the "powerhouses" of our cells that drive energy production. When mitochondrial health is compromised, it can lead to a range of issues, from poor energy levels to chronic diseases. Factors such as oxidative stress, poor diet, lack of exercise, and environmental toxins all play a role in mitochondrial dysfunction. In this episode, we'll explore: What metabolic health really means and why it's essential for overall well-being. How practitioners can simplify the concept for patients and emphasize the importance of lifestyle factors like diet, exercise, and stress management. The role of VO2 Max as a powerful yet underutilized tool for assessing cardiovascular and metabolic health. VO2 Max, which measures the body's ability to utilize oxygen during exercise, is one of the best indicators of mitochondrial and cardiovascular health. Despite its value, it's not used enough in clinical practice. We'll discuss why this metric matters and how it can be integrated into patient care to provide a more comprehensive picture of health. Join us for this insightful conversation as we redefine what it means to achieve and maintain metabolic health.

Harry Bane, CEO of Lifespan.MD and entrepreneur who created an 'entrepreneurial equity' concierge medicine partnership, explains a model that preserves clinician autonomy while sharing infrastructure. He contrasts this with private equity. Short segments cover collaborative practice networks, AI and tech scaling, 30–40% organic growth, and strategies to ease clinician burnout and succession planning.

Dr. Chris D'Adamo, an epidemiologist and clinical research leader, explains trial design and evidence for finished-product supplement trials. Miles Spar, MD, a men's health and performance clinician, discusses nitric oxide and hydrogen sulfide physiology. They explore how these gasotransmitters interact, results from a 600-person randomized trial, implications for vascular and sexual function, and clinical strategies for upstream endothelial care.

A deep dive into a protocol shown to reduce arterial calcium and plaque. Discussion of who can benefit and how genetics may affect results. Breakdown of core supplements used and how long to monitor for change. Comparison of drug therapy versus natural strategies. Practical guidance on diet, graded exercise, sleep, stress reduction, and a natural approach for heart failure support.

In this episode of the *Innovations and Clinical Implementation* podcast recorded at LongevityFest, hosts Tom Blue and Chris D'Adamo discuss the rapid evolution of epigenetic testing with Ryan Smith. Ryan Smith is the founder and global head of research and development at TruDiagnostic, a CLIA-certified lab and health data company that has built one of the world's largest private epigenetic databases to advance the measurement of biological aging. The discussion traces the 140% year-over-year growth in consumer interest regarding biological age and explores how TruDiagnostic utilizes AI to interpret over 1.3 million DNA methylation sites to validate longevity interventions in clinical trials. Smith previews the upcoming release of "methylation risk scores" that can predict the onset of diseases like COPD and Lyme disease, and details the development of "Epigenetic Biomarker Proxies" (EBPs) intended to eventually replace traditional labs by deriving thousands of metrics—such as HbA1c, CRP, and environmental toxins—from a single finger stick. For access to episode resources, click HERE.

Leo Grady, PhD, AI and microbiome founder; Helen Messier, MD, PhD, molecular immunologist and longevity clinician; Lawrence Kosinski, MD, gastroenterologist and value-based care leader. They discuss how AI decodes microbiome signatures before disease. Conversations cover gut–brain links, microbial metabolites like butyrate, TMAO and cardiovascular risk, effects of diet, fiber and drugs on microbiome, and clinical uses of fecal testing.